pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioPharma Dive·Aug 24·1 min read
save

Season 2 of The Progress Profile podcast spotlights Alzheimer’s research and patient-centered trial design

Aug 24, 2026·read at BioPharma Dive ↗Neutral

The Progress Profile: Alzheimer’s Research in Focus returns for a second season, offering conversations about Alzheimer’s disease and brain health.

In the premiere episode, Dr. John Harrison, Dr. Lon Schneider and Dr. Stephen Salloway discuss how to bridge the gap between clinical trial design and frontline care.

The experts highlight how insights from recent research are shaping more patient-centered approaches to treatment, measurement and long-term disease management.

The podcast is sponsored by Pearson and is available through BioPharma Dive’s studio platform.

source

This writeup was produced by pharmadog from original reporting by BioPharma Dive.

Original headline: “[Podcast] (Season 2) The Progress Profile: Alzheimer’s Research in Focus”

read at BioPharma Dive ↗
169 words · retrieved Jun 16
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADING

related stories

  • May 8OncLive Polls Reveal Picks for Top Lung Cancer Abstracts at ASCO 2026onclive
  • May 8Why we left the FDA: Six former officials share their storiesSTAT
  • May 8Opinion: We need more men in nursingSTAT
  • May 7Fraudulent citations, blamed on AI hallucinations, are becoming more common in research papersSTAT
  • May 7Sarepta tumbles as its gene therapy sales decline furtherBioPharma Dive